AMSL Diabetes, a Dexcom company, has issued an urgent Product Correction for the Dexcom G7 iOS App version 2.12 following agreement with the Therapeutic Goods Administration (TGA).

In Dexcom G7 iOS App version 2.12, only Critical Alerts are designed to override an iPhone’s Silent Mode or Focus Mode settings. Non-critical alerts will follow the phone’s notification settings.

As a result, if an affected device is set to Silent Mode or Focus Mode, some non-critical alerts may not sound. This could delay the detection of high or low glucose levels, which may have serious health consequences.

Affected Products

Product	Version
Dexcom G7 iOS App	Version 2.12

ARTG: 529343

What should you do?

1. Check whether you are using Dexcom G7 iOS App version 2.12.
2. If you are using version 2.12:
   • Open the Apple App Store
   • Search for the Dexcom G7 iOS App
   • Install the latest available version of the app
3. After updating:
   • Confirm the update has been successfully installed
   • Ensure phone notification settings are configured appropriately for glucose alerts

If you believe you are using an affected version of the Dexcom G7 iOS App and have not received a notification from Dexcom, contact Dexcom Technical Support at 1300 851 056. Individuals who have already been notified do not need to contact Dexcom unless they require assistance completing the recommended actions.

Why is Diabetes Australia sharing this notice?

Diabetes Australia is sharing this information because some people with diabetes may be using the affected version of the Dexcom G7 iOS App. It is important that users are aware of the issue and install the latest version to help ensure glucose alerts are received as intended.

Further information & references

• TGA Recall Reference Number: RC-2026-RN-00649-1
• Therapeutic Goods Administration (TGA) Recalls and Product Corrections
• AMSL Diabetes (Dexcom) Technical Support